Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice |
| |
Authors: | Anja K ster, Alexandra Montkowski, Stefan Schulz, Eva-Maria Stü be, Kristina Knaudt, Francois Jenck, Jean-Luc Moreau, Hans-Peter Nothacker, Olivier Civelli, Rainer K. Reinscheid |
| |
Affiliation: | F. Hoffmann-La Roche AG, Pharma Division, CNS Research, CH-4070 Basel, Switzerland. |
| |
Abstract: | The neuropeptide orphanin FQ (also known as nociceptin; OFQ/N) has been implicated in modulating stress-related behavior. OFQ/N was demonstrated to reverse stress-induced analgesia and possess anxiolytic-like activity after central administration. To further study physiological functions of OFQ/N, we have generated OFQ/N-deficient mice by targeted disruption of the OFQ/N gene. Homozygous mice display increased anxiety-like behavior when exposed to a novel and threatening environment. OFQ/N-null mice show elevated basal pain threshold but develop normal stress-induced analgesia. Interestingly, these mice show impaired adaptation to repeated stress when compared with wild-type mice, whereas their performance in spatial learning remained unaffected. Basal and poststress plasma corticosterone levels were found to be elevated in OFQ/N-deficient animals. Thus, OFQ/N appears to be crucially involved in the neurobiological regulation of stress-coping behavior and fear. |
| |
Keywords: | |
|
|